Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)
China
· Delayed Price · Currency is CNY 23.09
-1.03 (-4.27%)
Oct 11, 2024, 3:04 PM CST
Tibet Cheezheng Tibetan Medicine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,220 | 2,040 | 2,040 | 1,766 | 1,480 | 1,401 | Upgrade
|
| Other Revenue | 5.02 | 5.55 | 4.63 | 4.06 | 4.58 | 2.05 | Upgrade
|
| Revenue | 2,225 | 2,045 | 2,045 | 1,770 | 1,485 | 1,403 | Upgrade
|
| Revenue Growth (YoY) | 12.51% | 0.02% | 15.49% | 19.22% | 5.87% | 15.62% | Upgrade
|
| Cost of Revenue | 377.78 | 324.7 | 325.52 | 269.7 | 217.36 | 182.11 | Upgrade
|
| Gross Profit | 1,847 | 1,720 | 1,719 | 1,501 | 1,268 | 1,221 | Upgrade
|
| Selling, General & Admin | 1,268 | 1,162 | 1,107 | 986.35 | 828.33 | 824.3 | Upgrade
|
| Research & Development | 58.79 | 58.63 | 55.09 | 70.82 | 60.32 | 55.55 | Upgrade
|
| Other Operating Expenses | 44.74 | 32.26 | 29.47 | 28.58 | 25.68 | 22.32 | Upgrade
|
| Operating Expenses | 1,370 | 1,253 | 1,192 | 1,084 | 915.16 | 901.98 | Upgrade
|
| Operating Income | 477.27 | 467.52 | 527.71 | 416.45 | 352.54 | 318.58 | Upgrade
|
| Interest Expense | -83.12 | -63.07 | -56.42 | -53.43 | -22.31 | -4.67 | Upgrade
|
| Interest & Investment Income | - | 41.92 | 16.96 | 340.33 | 58.1 | 34.34 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.03 | -0.02 | -0.02 | -0.11 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.2 | -1.16 | -3.56 | -2.46 | -0.98 | -0.64 | Upgrade
|
| EBT Excluding Unusual Items | 394.35 | 445.19 | 484.68 | 700.88 | 387.24 | 347.58 | Upgrade
|
| Impairment of Goodwill | - | - | - | -15.77 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 62.17 | 37.07 | -37.08 | 20.69 | - | 2.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.17 | 0.32 | 0 | -0.07 | -0.35 | 1.81 | Upgrade
|
| Asset Writedown | -0.3 | -0.3 | -1.22 | -0.35 | -0.04 | -0.01 | Upgrade
|
| Other Unusual Items | 214.35 | 162.14 | 72.82 | 82.54 | 58.11 | 49.59 | Upgrade
|
| Pretax Income | 670.74 | 644.41 | 519.2 | 787.91 | 444.96 | 401.26 | Upgrade
|
| Income Tax Expense | 75.17 | 65.24 | 49.56 | 77.09 | 40.78 | 36.87 | Upgrade
|
| Earnings From Continuing Operations | 595.57 | 579.18 | 469.64 | 710.83 | 404.18 | 364.39 | Upgrade
|
| Minority Interest in Earnings | -0.95 | 2.02 | 2.9 | 5.05 | -0.22 | -0.14 | Upgrade
|
| Net Income | 594.62 | 581.2 | 472.54 | 715.88 | 403.96 | 364.25 | Upgrade
|
| Net Income to Common | 594.62 | 581.2 | 472.54 | 715.88 | 403.96 | 364.25 | Upgrade
|
| Net Income Growth | 7.63% | 22.99% | -33.99% | 77.21% | 10.90% | 14.27% | Upgrade
|
| Shares Outstanding (Basic) | 530 | 530 | 530 | 529 | 529 | 528 | Upgrade
|
| Shares Outstanding (Diluted) | 530 | 530 | 530 | 529 | 529 | 528 | Upgrade
|
| Shares Change (YoY) | 0.03% | -0.05% | 0.21% | 0.12% | 0.03% | -0.53% | Upgrade
|
| EPS (Basic) | 1.12 | 1.10 | 0.89 | 1.35 | 0.76 | 0.69 | Upgrade
|
| EPS (Diluted) | 1.12 | 1.10 | 0.89 | 1.35 | 0.76 | 0.69 | Upgrade
|
| EPS Growth | 7.59% | 23.05% | -34.13% | 77.01% | 10.87% | 14.88% | Upgrade
|
| Free Cash Flow | 148.6 | 458.59 | 13.29 | 909.35 | -101.7 | 353.68 | Upgrade
|
| Free Cash Flow Per Share | 0.28 | 0.87 | 0.03 | 1.72 | -0.19 | 0.67 | Upgrade
|
| Dividend Per Share | 0.960 | 0.480 | 0.390 | 0.590 | 0.340 | 0.350 | Upgrade
|
| Dividend Growth | 146.15% | 23.08% | -33.90% | 73.53% | -2.86% | 11.46% | Upgrade
|
| Gross Margin | 83.02% | 84.12% | 84.08% | 84.77% | 85.36% | 87.02% | Upgrade
|
| Operating Margin | 21.45% | 22.86% | 25.81% | 23.52% | 23.74% | 22.71% | Upgrade
|
| Profit Margin | 26.72% | 28.42% | 23.11% | 40.43% | 27.20% | 25.97% | Upgrade
|
| Free Cash Flow Margin | 6.68% | 22.42% | 0.65% | 51.36% | -6.85% | 25.21% | Upgrade
|
| EBITDA | 583.83 | 550.09 | 604.13 | 476.77 | 396.33 | 354.61 | Upgrade
|
| EBITDA Margin | 26.24% | 26.90% | 29.54% | 26.93% | 26.69% | 25.28% | Upgrade
|
| D&A For EBITDA | 106.56 | 82.57 | 76.42 | 60.32 | 43.79 | 36.03 | Upgrade
|
| EBIT | 477.27 | 467.52 | 527.71 | 416.45 | 352.54 | 318.58 | Upgrade
|
| EBIT Margin | 21.45% | 22.86% | 25.81% | 23.52% | 23.74% | 22.71% | Upgrade
|
| Effective Tax Rate | 11.21% | 10.12% | 9.55% | 9.78% | 9.17% | 9.19% | Upgrade
|
| Revenue as Reported | 2,225 | 2,045 | 2,045 | 1,770 | 1,485 | 1,403 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 3.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.